Write For Us

FDA narrows patient group for Biogen's Alzheimer's drug

Sponsored Post Vitamin D2 Canada Persia
98 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Biogen said the U.S. drug regulator has narrowed the patient group that can use its Alzheimer's disease drug, after the agency drew sharp criticism for approving the drug last month without proof of clear benefit against the disease.

#Biogen #Alzheimer #Aduhelm #FDA #News #Reuters

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, business, finance
Sign in or sign up to post comments.
Be the first to comment